Impact of Continuing Medical Education (CME) Insulin Program
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00824603|
Recruitment Status : Completed
First Posted : January 19, 2009
Last Update Posted : December 2, 2015
|Condition or disease|
We will determine whether attendees' self-reported confidence and use of insulin with persons with type 2 diabetes changes after they attend the CME program. Specifically, we will address the following questions:
Question 1. Clinical guidelines. Is insulin initiated earlier (at a lower A1C)?
Question 2. Decision-making. Does confidence in selecting a starting insulin regimen change? Does confidence in selecting a starting insulin dose change? Does confidence in adjusting insulin change? Does confidence in discussion nutrition guidelines change?
Question 3. Application. Do more patients start using insulin? Who usually selects starting dose? How is starting dose selected? How often is insulin adjusted?
Question 4. Resources. How available are protocols for insulin use? How available is adequate time to monitor insulin therapy? How available is staff to teach insulin injections? How available is staff to help adjust insulin?
|Study Type :||Observational|
|Actual Enrollment :||294 participants|
|Official Title:||Impact of CME Program on Self-Reported Confidence and Use of Insulin in Persons With Type 2 Diabetes|
|Study Start Date :||June 2006|
|Primary Completion Date :||August 2009|
|Study Completion Date :||August 2009|
primary care provider
attending insulin CME Training
- We will determine whether attendees' self-reported confidence and use of insulin with persons with type 2 diabetes changes after they attend the CME program. [ Time Frame: pre program survey & 2-4 month post program survey ]
- pre-CME training level of patient's A1c when starting insulin therapy compared to post-CME training level of patient's A1c when starting insulin therapy [ Time Frame: pre program survey and 2-4 month post program survey ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00824603
|United States, Minnesota|
|International Diabetes Center|
|Minneapolis, Minnesota, United States, 55416|
|Principal Investigator:||Margaret Powers, PhD||International Diabetes Center at Park Nicollet|